Revolutionary Technologies for Precision Medicine

Who we are

Kinomica is a pioneering precision medicine research and diagnostics company specialising in cell signalling with an interdisciplinary phosphoproteomics platform that combines LC-MS/MS with advanced proprietary bioinformatics to provide bespoke R&D and diagnostic services.

Jane Theaker, Chief Executive Officer, Kinomica

Arrange a technical call

Services

icon showing a microscope

Pre-Clinical

Effective and expedited analyses and data that minimise the time of your study.

good clinical laboratory practice (GCLP) icon

GcLP

Samples processed for Clinical trials using LC-MS/MS and KScan analysis to Good Clinical Laboratory Practices standards.

Applications

AML Project

Acute myeloid leukaemia (AML) patients are currently treated with a drug called Midostaurin which is prescribed after taking a DNA test which looks for mutations in the FLT3 gene.

Mobile AML image

Kinomica has data from preclinical samples which shows that the predictive value is more than doubled by using LC-MS/MS mass spectrometry and KScan data analysis instead of the DNA test.

News

Kinomica has been named as one of NW Business Insiders ‘Most Exciting Companies’

Kinomica is delighted to be named as one of North West Business Insider’s ‘Most Exciting Companies!’ by Insider Media.

Kinomica is delighted to be named as one of North West Business Insider’s ‘Most Exciting Companies!’ by Insider Media.

Read more >>
Read more >>
Kinomica is a finalist in the UK Business Angels Association Awards

The UKBAA Angel Investment Awards is aimed at recognising and acknowledging the founders, angels, crowd funders and early-stage venture capital investors behind them who have adapted and grown through the COVID-19 pandemic. It is a great way to celebrate the success & determination of the angel and early-stage investment community.

The UKBAA Angel Investment Awards is aimed at recognising and acknowledging the founders, angels, crowd funders and early-stage venture capital investors behind them who have adapted and grown through the COVID-19 pandemic. It is a great way to celebrate the success & determination of the angel and early-stage investment community.

Read more >>
Read more >>
Kinomica are attending OBN’s Biotrinity 2021 conference

Kinomica is excited to attending OBN’s BioTrinity 2021 conference later this month, and contributing as one of their BioLaunchPad showcase companies.

Kinomica is excited to attending OBN’s BioTrinity 2021 conference later this month, and contributing as one of their BioLaunchPad showcase companies.

Read more >>
Read more >>
Kinomica presents a Poster at this year’s online ASCO conference

The 2021 ASCO (American Society of Clinical Oncology) Annual Meeting features a dynamic programme of educational and scientific sessions, showcasing what is possible when the cancer care community comes together to advance cancer research, treatment and patient care.

The 2021 ASCO (American Society of Clinical Oncology) Annual Meeting features a dynamic programme of educational and scientific sessions, showcasing what is possible when the cancer care community comes together to advance cancer research, treatment and patient care.

Read more >>
Read more >>

Arrange a technical call